ONCO - Onconetix, Inc.

0.6747
-0.046   -6.862%

Share volume: 1,467,157
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%
$0.72
-0.05
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
35%
Profitability 35%
Dept financing 38%
Liquidity 10%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.78%
1 Month
-44.70%
3 Months
-73.80%
6 Months
-75.73%
1 Year
195.92%
2 Year
110.84%
Key data
Stock price
$0.67
P/E Ratio 
0.00
DAY RANGE
$0.63 - $0.80
EPS 
-$6.78
52 WEEK RANGE
$0.05 - $5.93
52 WEEK CHANGE
$194.89
MARKET CAP 
4.371 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$788,870
AVERAGE 30 VOLUME 
$711,671
Company detail
CEO: Ralph Schiess
Region: US
Website: onconetix.gcs-web.com
Employees: 12
IPO year: 2022
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

Recent news